The backlash against direct-to-consumer (DTC) drug ads during the Super Bowl may not have been as furious as the backlash against Beyonce's tribute to Malcolm X, the Black Panthers and Black Lives Matter, but it did involve the White House, which specifically criticized a "PSA" about opioid-induced constipation (OIC). The ad was funded by AstraZeneca and Daiichi Sankyo, two companies in a joint venture to market Movantik, a drug that treats OIC.
The ad drew criticism from other quarters as well.
Read more »
The ad drew criticism from other quarters as well.
Read more »
Super Bowl DTC Drug Ads Spark Backlash!
![Super Bowl DTC Drug Ads Spark Backlash!]()
Reviewed by admin
on
February 10, 2016
Rating:
No comments: